Concepedia

Publication | Open Access

The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8+ T cell exhaustion

10

Citations

45

References

2025

Year

Abstract

CD8<sup>+</sup> T cell exhaustion (T<sub>ex</sub>) limits immune control of cancer, but the underlying molecular drivers are unclear. In the present study, we identified the prostaglandin I<sub>2</sub> (prostacyclin) receptor PTGIR as a cell-intrinsic regulator of T cell exhaustion. Transcriptomic profiling of terminally exhausted (T<sub>t</sub><sub>ex</sub>) CD8<sup>+</sup> T cells revealed increased activation of the nuclear factor erythroid 2-related factor 2 (NRF2) oxidative stress response pathway. Enhancing NRF2 activity (by conditional deletion of Kelch-like ECH-associated protein 1 (KEAP1)) boosts glutathione production in CD8<sup>+</sup> T cells but accelerates terminal exhaustion. NRF2 upregulates PTGIR expression in CD8<sup>+</sup> T cells. Silencing PTGIR expression enhances T cell effector function (that is, interferon-γ and granzyme production) and limits T<sub>tex</sub> cell development in chronic infection and cancer models. Mechanistically, PTGIR signaling impairs T cell metabolism and cytokine production while inducing transcriptional features of T<sub>ex</sub> cells. These findings identify PTGIR as a NRF2-dependent immune checkpoint that regulates balance between effector and exhausted CD8<sup>+</sup> T cell states.

References

YearCitations

Page 1